6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: XTL BIOPHARMACEUTICALS LTD
Filed: September 4, 2019
Period of Report: September 4, 2019
Accession Number: 0001213900-19-017185

View Document ↗ View on SEC.gov ↗